ASHP and College Partnership Brings Launch of Pharmacogenomics Accelerator

After more than a year of partnership exploration, team formation and project planning, the American Society of Health System Pharmacists (ASHP) has announced the launch of the first cohort of the Pharmacogenomics Accelerator™. The accelerator is offered through a partnership between the University of Minnesota College of Pharmacy and ASHP. 

“This is an important milestone in what is expected to be a multi-year partnership with ASHP,” said Dr. Todd Sorensen, senior executive associate dean for strategic initiatives and faculty affairs. “The program creates a platform where the college is catalyzing and supporting the adoption of pharmacogenomics on a national scale.”

Collegiate leads for this program, Dr. David Stenehjem, associate professor and associate head of the Department of Pharmacy Practice and Pharmaceutical Sciences, and Dr. Lindsay Sorge, senior strategic initiatives lead, have worked closely with ASHP staff to create a novel program design that is immersive and follows leading practices in clinical program implementation. Organizations enrolled in the PGx Accelerator will also participate in the PGx ECHO managed by the college and led by Dr. Pam Jacobson, professor and director of the Institute of Personalized Medicine.

“In addition to being aligned with our strategic plan, this effort also illustrates our collegiate values in action, specifically our values of excellence and of curiosity, creativity and innovation,” said Sorensen. “A commitment to these values has supported the success of this program, which is one new way we are advancing the impact of our college in health care.”